MOH — authorised 30 August 2012
- Marketing authorisation holder: FOREST LABS LLC
- Status: likely_approved
MOH authorised Linzess on 30 August 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 August 2012.
FOREST LABS LLC holds the Israeli marketing authorisation.